This Core will serve as a central facility to collect and process blood for serum and lymphocytes, and tumor tissues for initiation of tissue culture cell lines and cryopreservation of tissue minces. This will be done according to the standard operating procedures (SOPs) to promote uniformity in handling and record-keeping of the samples received from the various centers participating in the trial as well as from the JWCI clinics. The centralized collection and processing of specimens will allow efficient use of materials, reduce the frequency of venipuncture, and allow maintenance of process uniformity, thus preserving the highest possible quality of the specimens to be used by leaders in various projects. The procedures will include the following: (1) Centralized processing of blood specimens received from JWCI and participating trial centers for serum and lymphocytes; (2) Cryopreservation and inventorying of the separated serum and lymphocytes into freezers at pre-assigned locations, and maintenance of appropriate records in computerized database; (3) Retrieval and distribution of cryopreserved specimens to leaders of various projects as needed; (4) Processing of tumor tissues for cryopreservation as tissue minces and initiation of primary cell lines; (5) Maintenance of tumor cell lines, and retrieval and distribution of cells to leaders of various projects; and (6) Target antigen purification from spent-culture medium, tumor cell extracts and urine of cancer patients according to already established procedures. The specimens upon receipt will be examined for physical appearance and checked for accuracy of the information and appropriateness of the accompanying forms. Information that will accompany the specimen will be verified with pathology reports. To maintain confidentiality, the specimens will be coded and appropriate records maintained at a central location.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
2P01CA012582-31
Application #
6581152
Study Section
Project Start
2002-04-15
Project End
2007-03-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
31
Fiscal Year
2002
Total Cost
$53,375
Indirect Cost
Name
John Wayne Cancer Institute
Department
Type
DUNS #
556074458
City
Santa Monica
State
CA
Country
United States
Zip Code
90404
Dükel, Muzaffer; Streitfeld, W Scott; Tang, Tsz Ching Chloe et al. (2016) The Breast Cancer Tumor Suppressor TRIM29 Is Expressed via ATM-dependent Signaling in Response to Hypoxia. J Biol Chem 291:21541-21552
Kiyohara, Eiji; Hata, Keisuke; Lam, Stella et al. (2014) Circulating tumor cells as prognostic biomarkers in cutaneous melanoma patients. Methods Mol Biol 1102:513-22
Greenberg, Edward S; Chong, Kelly K; Huynh, Kelly T et al. (2014) Epigenetic biomarkers in skin cancer. Cancer Lett 342:170-7
Chiu, Connie G; Nakamura, Yoshitaka; Chong, Kelly K et al. (2014) Genome-wide characterization of circulating tumor cells identifies novel prognostic genomic alterations in systemic melanoma metastasis. Clin Chem 60:873-85
Faries, Mark B; Steen, Shawn; Ye, Xing et al. (2013) Late recurrence in melanoma: clinical implications of lost dormancy. J Am Coll Surg 217:27-34; discussion 34-6
Leung, Anna M; Hari, Danielle M; Morton, Donald L (2012) Surgery for distant melanoma metastasis. Cancer J 18:176-84
Kidner, Travis B; Morton, Donald L; Lee, Delphine J et al. (2012) Combined intralesional Bacille Calmette-Guérin (BCG) and topical imiquimod for in-transit melanoma. J Immunother 35:716-20
Hoshimoto, Sojun; Shingai, Tatsushi; Morton, Donald L et al. (2012) Association between circulating tumor cells and prognosis in patients with stage III melanoma with sentinel lymph node metastasis in a phase III international multicenter trial. J Clin Oncol 30:3819-26
Hoshimoto, Sojun; Kuo, Christine T; Chong, Kelly K et al. (2012) AIM1 and LINE-1 epigenetic aberrations in tumor and serum relate to melanoma progression and disease outcome. J Invest Dermatol 132:1689-97
Faries, Mark B; Morton, Donald L (2012) Staging of regional nodes in pulmonary malignancies. Ann Surg Oncol 19:703-5

Showing the most recent 10 out of 238 publications